Biohaven amends option agreements for CEO, CFO, CSO; annual meeting results

Biohaven Ltd.

Amended option agreements permit CEO Coric, CFO Buten, CSO Car to exercise options pre-vest in exchange for restricted shares.
Annual meeting turnout: 87.78% of 68,212,479 shares represented.
Directors elected: Heffernan (86.42%), Antonijevic (94.47%), Hugin (94.02%).
Ratification of Ernst & Young as auditor approved with 99.87% of votes cast.

Key facts

Extracted from this filing and checked against the source text.

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Biohaven Ltd. shareholders approved Ratification of the appointment of Ernst & Young LLP as independent auditors for the fiscal year ending December 31, 2023 at the 2023-05-02 meeting.

Proposal: auditor ratification
Outcome: passed
Meeting: 2023-05-02

Exact text from the filing

Proposal No. 2 : Ratification of the appointment of Ernst & Young LLP as independent auditors for the fiscal year ending December 31, 2023.

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Biohaven Ltd. shareholders approved Election of Directors for a term expiring at the 2026 Annual Meeting of Shareholders at the 2023-05-02 meeting.

Proposal: director election
Outcome: passed
Meeting: 2023-05-02

Exact text from the filing

Proposal No. 1 : Election of Directors for a term expiring at the 2026 Annual Meeting of Shareholders.

View on SEC.gov

Browse all shareholder votes →

Biohaven Ltd. filing history →

Source: SEC EDGAR

accession 0001935979-23-000019

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.